Vlad Mazanko is Ukraine-based gaming enthusiast, writing about the industry since 2013 and covering everything from games and studios to movies and TV shows. He joined the Valnet family back in 2021, ...

It's almost time for the 158th Belmont Stakes, the final jewel in the Triple Crown. There will be no Triple Crown winner this year, though, after the Kentucky Derby winner Golden Tempo sat out for the ...

It was May 2020, and like much of the world, I wasn’t quite sure how the Covid-19 pandemic was going to pan out. I was restlessly working from home, yearning to get outside, which conveniently, was ...

The No. 8 car now belongs to Brexton Busch now. He just has to grow into it. Richard Childress Racing announced Friday, May 22 that it is suspending use of the number Kyle Busch made famous, driving ...

KANSAS CITY, Mo. — Richard Childress Racing (RCR) announced on Friday it has elected to suspend use of the No. 8 car following the death of Kyle Busch at the age of 41. RCR said it will run the No. 33 ...

Richard Childress Racing, Kyle Busch’s racing team, says it will no longer use the late driver’s No. 8 car, unless his son, Brexton Busch, goes pro and wants it when the time comes. “Richard Childress ...

Forza Horizon 6 players are exploiting certain parts of the game so that they can quickly and easily unlock every vehicle in the game. As spotted by GamesRadar ...

Isack Hadjar exits his crashed Red Bull car during the 2026 Miami Grand Prix. Clive Mason / Getty Images The 2026 cars rolled out of the garage at the Australian Grand Prix and into one of the most ...

Drag races in Forza Horizon 6 are some of the most addictive and fun. They’re very straightforward, end fast, and don’t require as much actual skill as something like maintaining a perfect drift (we ...

Players already know that the GR GT Prototype (2025) is featured on the Forza Horizon 6 cover art, next to the Toyota Land Cruiser (2025), and it’s built for Road Races. It’s an excellent, stylish, ...

CREATE Medicines is working on a clinical-stage pipeline for cancer, while its autoimmune programs are still in preclinical testing. CAR T specialist CREATE Medicines has raised $122 million to ...

Cambridge-based Create Medicines announced Thursday it has raised another $122 million to bolster its cell therapy capabilities across cancers and autoimmune conditions. The Series B financing round ...